- Investing Ideas
- /
- Media Healthcare Sector
Media Healthcare Sector
Results
2308
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,308 companies
Traws Pharma
Market Cap: US$6.0m
A clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer.
TRAW
US$1.19
7D
-14.4%
1Y
-92.6%
Genprex
Market Cap: US$6.0m
A clinical-stage gene therapy company, focuses on developing gene-based therapies for patient populations with unmet medical needs.
GNPX
US$0.25
7D
-10.4%
1Y
-89.9%
Bionoid Pharma
Market Cap: US$5.9m
Engages in the hemp cultivation business.
BINP
US$0.11
7D
10.0%
1Y
n/a
Unified Global
Market Cap: US$5.9m
Operates as a vertically integrated cannabis company in Canada and the United States.
CHYL
US$0.10
7D
0%
1Y
n/a
MetaVia
Market Cap: US$5.9m
A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.
MTVA
US$0.68
7D
-2.3%
1Y
-85.1%
GENinCode
Market Cap: UK£4.4m
Develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient’s health based on their genes in the United Kingdom and internationally.
GENI
UK£0.015
7D
-3.1%
1Y
-81.2%
Soligenix
Market Cap: US$5.9m
A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.
SNGX
US$1.86
7D
-4.9%
1Y
-69.7%
SunLink Health Systems
Market Cap: US$5.8m
Through its subsidiaries, provides healthcare products and services in the southeastern United States.
SSY
US$0.83
7D
-6.1%
1Y
37.7%
Pasithea Therapeutics
Market Cap: US$5.8m
A clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.
KTTA
US$0.96
7D
9.9%
1Y
-85.6%
Biofrontera
Market Cap: US$5.8m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$0.65
7D
-4.8%
1Y
-40.9%
Mobile-health Network Solutions
Market Cap: US$5.7m
An investment holding company, provides telehealth solutions primarily in Singapore.
MNDR
US$1.33
7D
-5.0%
1Y
-91.4%
Kovo+ Holdings
Market Cap: CA$8.0m
Operates as a healthcare technology company.
KOVO
CA$0.045
7D
0%
1Y
80.0%
Sigyn Therapeutics
Market Cap: US$5.7m
A development-stage company, provides therapeutic solutions to treat cancer and infectious disease disorders in the United States.
SIGY
US$3.53
7D
0%
1Y
-32.8%
GT Biopharma
Market Cap: US$5.7m
A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.
GTBP
US$2.23
7D
-3.0%
1Y
-71.4%
AEON Biopharma
Market Cap: US$5.7m
A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.
AEON
US$0.50
7D
1.6%
1Y
-99.6%
Sproutly Canada
Market Cap: CA$7.6m
Produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumables markets in Canada.
SPR
n/a
7D
n/a
1Y
n/a
Lipella Pharmaceuticals
Market Cap: US$5.6m
A clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications.
LIPO
US$2.18
7D
-11.0%
1Y
-63.9%
Univec
Market Cap: US$5.5m
Provides health care services in the United States.
UNVC
US$0.0022
7D
0%
1Y
-54.2%
Argent BioPharma
Market Cap: AU$8.7m
A multidisciplinary drug development Company, engages in the provision of medicines targeting immunology and neurology worldwide.
RGT
AU$0.12
7D
-20.0%
1Y
-67.1%
Cardiac Biotech Solutions
Market Cap: US$5.5m
Through its subsidiaries, provides various products and services in the ambulatory non-invasive cardiac monitoring space in the United States and internationally.
CBSC
US$0.034
7D
-8.4%
1Y
-51.3%
Frequency Exchange
Market Cap: CA$7.6m
Focuses on the development and commercialization of a wearable frequency delivery system that provides programs for health, wellness, and performance enhancement.
FREQ
CA$0.16
7D
-27.3%
1Y
33.3%
Sunshine Biopharma
Market Cap: US$5.5m
Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
SBFM
US$1.50
7D
11.1%
1Y
-92.3%
Check-Cap
Market Cap: US$5.4m
A clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.
CHEK
US$0.93
7D
13.5%
1Y
-57.6%
Apollomics
Market Cap: US$5.4m
A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to eradicate cancer.
APLM
US$4.89
7D
-4.8%
1Y
-84.6%
StateHouse Holdings
Market Cap: CA$7.7m
An integrated omni-channel cannabis company, engages in the cultivation, processing, manufacture, distribution, and retailing of cannabis products for the adult-use and medical markets in the United States.
STHZ
CA$0.03
7D
0%
1Y
-45.5%
FutureNet
Market Cap: US$5.4m
This record represents the public shell of FutureNet Inc.
FUUN
US$0.011
7D
0%
1Y
-56.4%
Regional Health Properties
Market Cap: US$5.3m
Operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living.
RHEP
US$2.60
7D
16.6%
1Y
-6.0%
Burzynski Research Institute
Market Cap: US$5.3m
Engages in the research and development of antineoplaston drugs for the treatment of various cancers.
BZYR
US$0.04
7D
26.9%
1Y
3.0%
BioCorRx
Market Cap: US$5.3m
Through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States.
BICX
US$0.31
7D
8.5%
1Y
-61.6%
Caduceus Software Systems
Market Cap: US$5.3m
Through its subsidiary, McLovin's Pet Food, Inc., operates as a pet food and pet care company.
CSOC
US$0.007
7D
7.7%
1Y
-43.1%
N4 Pharma
Market Cap: UK£4.0m
A specialist pharmaceutical company, develops silica nanoparticle delivery systems to enhance the cellular delivery of cancer treatments, gene therapy, and vaccines in the United Kingdom.
N4P
UK£0.0047
7D
-13.6%
1Y
-40.6%
Sonoma Pharmaceuticals
Market Cap: US$5.2m
Develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
SNOA
US$3.23
7D
1.9%
1Y
-28.9%
Quantumzyme
Market Cap: US$5.2m
Operates as a biotransformation company.
QTZM
US$0.15
7D
199.8%
1Y
n/a
HITIQ
Market Cap: AU$8.0m
Engages in development and commercialization of concussion management technology and software in Australia.
HIQ
AU$0.02
7D
0%
1Y
25.0%
American Films
Market Cap: US$5.1m
Does not have significant operations.
AMFL
US$0.08
7D
-5.2%
1Y
-59.3%
Clearmind Medicine
Market Cap: US$5.1m
A clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.
CMND
US$0.99
7D
0.2%
1Y
-17.5%